Clinical Trial Update: GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating GTI-2040 with docetaxel and prednisone in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• GTI-2040 (GTI-2040)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED